Jan 23 (Reuters) - Invitrocue Ltd IVQ.AX :
* INVITROCUE SIGNS TECHNOLOGY DEVELOPMENT AGREEMENT TO INCLUDE INDICATIONS FOR MULTIPLE BREAST CANCER SUBTYPES
* TECHNOLOGY DEVELOPMENT AGREEMENT SIGNED WITH SHANGHAI INSTITUTE OF BIOCHEMISTRY & CELL BIOLOGY (SIBCB), CHINESE ACADEMY OF SCIENCES
* INTELLECTUAL PROPERTY (IP) TO BE OWNED BY BOTH PARTIES & CO TO BE GRANTED GLOBAL COMMERCIALISATION RIGHTS TO ANY IP DEVELOPED